BGB-B3227
BGB-B3227-101
Phase 1 small_molecule terminated
Quick answer
BGB-B3227 for Advanced Cancer is a Phase 1 program (small_molecule) at BeOne Medicines with 1 ClinicalTrials.gov record(s).
Program details
- Company
- BeOne Medicines
- Indication
- Advanced Cancer
- Phase
- Phase 1
- Modality
- small_molecule
- Status
- terminated